Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.
Blood Adv. 2022 May 10;6(9):2835-2846. doi: 10.1182/bloodadvances.2021006166.
Blood Adv. 2022.
PMID: 35081257
Free PMC article.